000 01316 a2200397 4500
005 20250516133124.0
264 0 _c20131101
008 201311s 0 0 jpn d
022 _a1340-2544
040 _aNLM
_beng
_cNLM
100 1 _aAmano, Taku
245 0 0 _a[The lipid metabolism abnormality in patients administered with olanzapine].
_h[electronic resource]
260 _bNihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology
_cNov 2012
300 _a257-61 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aBenzodiazepines
_xtherapeutic use
650 0 4 _aBlood Glucose
_xphysiology
650 0 4 _aBody Mass Index
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInsulin
_xblood
650 0 4 _aLipid Metabolism
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOlanzapine
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aWeight Gain
700 1 _aHosaka, Shigetoshi
700 1 _aTakami, Hiroshi
700 1 _aSugiyama, Chie
700 1 _aOda, Kazue
700 1 _aMorikawa, Ryuichi
773 0 _tNihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology
_gvol. 32
_gno. 5-6
_gp. 257-61
999 _c22469735
_d22469735